Helixmith Co., Ltd.

This study looked at the long-term safety of a drug called Engensis in 8 people with ALS who had already received it in a previous study. Researchers monitored side effects over 6 months. The goal was to see if repeated doses remain safe, not to measure if the drug slows or stops…

This early-phase study tested whether a gene therapy called VM202 is safe for people with critical limb ischemia, a severe form of peripheral artery disease that causes pain and wounds. Twelve adults who had not improved with standard treatments received injections into their leg…

This early-stage study tested the safety of a new drug called VM202 in 18 people with amyotrophic lateral sclerosis (ALS). Participants received injections into their muscles to see if the treatment was safe and tolerable. The main goal was to track any side effects over 9 months…